Douglas Evan Godshall, President & CEO at Shockwave Medical, Inc. (SWAV), sold 7,100 shares at $171.56 ($1.2M) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($1.2M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.56 | 1,100 | $189K | 15.2% |
| 2 | $172.82 | 900 | $156K | 12.6% |
| 3 | $173.93 | 500 | $87K | 7.0% |
| 4 | $175.11 | 1,186 | $208K | 16.8% |
| 5 | $175.11 | 1,186 | $208K | 16.8% |
| 6 | $175.82 | 914 |
| $161K |
| 13.0% |
| 7 | $175.82 | 914 | $161K | 13.0% |
| 8 | $177.02 | 400 | $71K | 5.7% |
| Total | $174.48 avg | 7,100 | $1.2M | 100% |
| Filing → |
| SWAV | SELL | 2024-01-08 | $2.0M | — | Filing → |
| SWAV | SELL | 2023-12-18 | $1.7M | — | Filing → |
| SWAV | SELL | 2023-10-17 | $2.8M | — | Filing → |